81 related articles for article (PubMed ID: 28347751)
1. The duality of macrophage function in chronic lymphocytic leukaemia.
Chen YCE; Mapp S; Blumenthal A; Burgess ML; Mazzieri R; Mattarollo SR; Mollee P; Gill D; Saunders NA
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):176-182. PubMed ID: 28347751
[TBL] [Abstract][Full Text] [Related]
2. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
Hanna BS; Öztürk S; Seiffert M
Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
[TBL] [Abstract][Full Text] [Related]
3. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
[TBL] [Abstract][Full Text] [Related]
4. B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.
Galletti G; Caligaris-Cappio F; Bertilaccio MT
Leukemia; 2016 Dec; 30(12):2293-2301. PubMed ID: 27677742
[TBL] [Abstract][Full Text] [Related]
5. Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole.
Frezzato F; Trimarco V; Martini V; Gattazzo C; Ave E; Visentin A; Cabrelle A; Olivieri V; Zambello R; Facco M; Zonta F; Cristiani A; Brunati AM; Moro S; Semenzato G; Trentin L
Br J Haematol; 2014 Jun; 165(5):659-72. PubMed ID: 24606526
[TBL] [Abstract][Full Text] [Related]
6. Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.
Polk A; Lu Y; Wang T; Seymour E; Bailey NG; Singer JW; Boonstra PS; Lim MS; Malek S; Wilcox RA
Clin Cancer Res; 2016 Dec; 22(24):6118-6128. PubMed ID: 27334834
[TBL] [Abstract][Full Text] [Related]
7. Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.
Burgess M; Mapp S; Mazzieri R; Cheung C; Chambers L; Mattarollo SR; Mollee P; Gill D; Saunders NA
Oncogene; 2017 Apr; 36(17):2366-2376. PubMed ID: 27748757
[TBL] [Abstract][Full Text] [Related]
8. Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression.
Galletti G; Scielzo C; Barbaglio F; Rodriguez TV; Riba M; Lazarevic D; Cittaro D; Simonetti G; Ranghetti P; Scarfò L; Ponzoni M; Rocchi M; Corti A; Anselmo A; van Rooijen N; Klein C; Ries CH; Ghia P; De Palma M; Caligaris-Cappio F; Bertilaccio MTS
Cell Rep; 2016 Feb; 14(7):1748-1760. PubMed ID: 26876171
[TBL] [Abstract][Full Text] [Related]
9. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.
Haiat S; Billard C; Quiney C; Ajchenbaum-Cymbalista F; Kolb JP
Immunology; 2006 Jul; 118(3):281-92. PubMed ID: 16827889
[TBL] [Abstract][Full Text] [Related]
10. Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.
Seymour JF; Ma S; Brander DM; Choi MY; Barrientos J; Davids MS; Anderson MA; Beaven AW; Rosen ST; Tam CS; Prine B; Agarwal SK; Munasinghe W; Zhu M; Lash LL; Desai M; Cerri E; Verdugo M; Kim SY; Humerickhouse RA; Gordon GB; Kipps TJ; Roberts AW
Lancet Oncol; 2017 Feb; 18(2):230-240. PubMed ID: 28089635
[TBL] [Abstract][Full Text] [Related]
11. Novel X-linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL-mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis.
Frenzel LP; Patz M; Pallasch CP; Brinker R; Claasen J; Schulz A; Hallek M; Kashkar H; Wendtner CM
Br J Haematol; 2011 Jan; 152(2):191-200. PubMed ID: 21091905
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the role of protein kinase C in chronic lymphocytic leukaemia.
Michie AM; Nakagawa R
Hematol Oncol; 2006 Sep; 24(3):134-8. PubMed ID: 16841369
[TBL] [Abstract][Full Text] [Related]
13. Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?
Filip AA; Ciseł B; Koczkodaj D; Wąsik-Szczepanek E; Piersiak T; Dmoszyńska A
Blood Cells Mol Dis; 2013 Apr; 50(4):263-70. PubMed ID: 23313631
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia.
Elliott SL; Crawford C; Mulligan E; Summerfield G; Newton P; Wallis J; Mainou-Fowler T; Evans P; Bedwell C; Durkacz BW; Willmore E
Br J Haematol; 2011 Jan; 152(1):61-71. PubMed ID: 21083655
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.
Patz M; Isaeva P; Forcob N; Müller B; Frenzel LP; Wendtner CM; Klein C; Umana P; Hallek M; Krause G
Br J Haematol; 2011 Feb; 152(3):295-306. PubMed ID: 21155758
[TBL] [Abstract][Full Text] [Related]
17. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Stilgenbauer S; Eichhorst B; Schetelig J; Coutre S; Seymour JF; Munir T; Puvvada SD; Wendtner CM; Roberts AW; Jurczak W; Mulligan SP; Böttcher S; Mobasher M; Zhu M; Desai M; Chyla B; Verdugo M; Enschede SH; Cerri E; Humerickhouse R; Gordon G; Hallek M; Wierda WG
Lancet Oncol; 2016 Jun; 17(6):768-778. PubMed ID: 27178240
[TBL] [Abstract][Full Text] [Related]
18. The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.
Hofbauer SW; Krenn PW; Piñόn Hofbauer J; Pucher S; Asslaber D; Egle A; Hartmann TN; Greil R
Br J Haematol; 2016 Mar; 172(5):815-9. PubMed ID: 26147087
[No Abstract] [Full Text] [Related]
19. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
20. Association between chronic lymphocytic leukaemia and secondary tumours: unusual occurrence of a neuroendocrine (Merkell cell) carcinoma.
Quaglino D; Di Leonardo G; Lalli G; Pasqualoni E; Di Simone S; Vecchio L; Ventura T
Eur Rev Med Pharmacol Sci; 1997; 1(1-3):11-6. PubMed ID: 9444793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
